Technology area: Biotechnology & Pharmaceuticals
1 pending office actions • 1 art units • 1 examiners • 0 of 1 (0%) have an AI response strategy ready
Guangzhou Medical University Property Operation Limited Corporation currently manages 3 pending office actions within the Biotechnology & Pharmaceuticals technology area. This prosecution activity is distributed across distinct examiners, indicating a focused but divided examination footprint. The use of distinct art units suggests that the subject matter spans different specialized groups within the patent office. Practitioners should note that with distinct examiners involved in 3 pending office actions, there is a relatively high degree of examiner concentration per application.
The busiest examiner for this portfolio is MELLER, MICHAEL V, who is responsible for 2 of the pending office actions. This concentration means a particular examiner handles the larger share of the current workload. This centralized oversight by MELLER, MICHAEL V may allow for more consistent negotiation across the pending office actions under their review. Because the portfolio involves distinct examiners, the applicant must balance a unified strategy with the specific requirements of each individual reviewer. The presence of 2 distinct art units further necessitates a strategy that accounts for potential differences in examination culture between those specific groups.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 1 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| HUTTER, GILLIAN A | 1 | 54.5% | +46.2% |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17920731 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | HUTTER, GILLIAN A | 5d overdue |
| Art Unit | Apps |
|---|---|
| 1625 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 17920731 | APPLICATION OF COMPOUNDS IN CONTROLLING OR KILLING MITES | HUTTER, GILLIAN A | 1625 | §103 | Final Rejection | 5d overdue | Pending | Oct 21, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial